Abiraterone and its Impurities

Abiraterone is an active metabolite of Abiraterone acetate which is a steroidal antiandrogen and used in the treatment of metastatic castration-resistant prostate cancer. It is also known as a hormone therapy drug. It is sold under the brand name of Zytiga, Abiratas, Abretone, Abirapro). Reference standards of Abiraterone API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 31 results for Abiraterone Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 28 26000

Abiraterone

Abiraterone


  • Catalogue No.:PA 28 26000

  • CAS :

    154229-19-3

  • Molecular Formula : C24H31NO

  • Molecular Weight : 349.51

Drug Reference Standards & Impurity Synthesis in India
PA STI 001040

Abiraterone-d4

Abiraterone-d4


  • Catalogue No.:PA STI 001040

  • CAS :

    2122245-62-7

  • Molecular Formula : C24H27D4NO

  • Molecular Weight : 353.53

Drug Reference Standards & Impurity Synthesis in India
PAI 01 040010

(3S,8S,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,8S,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol


  • Catalogue No.:PAI 01 040010

  • CAS :

    NA

  • Molecular Formula : C24H33NO

  • Molecular Weight : 351.53

Drug Reference Standards & Impurity Synthesis in India
PAI 01 040020

3-((8S,9S,10R,13S,14S)-10,13-Dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine

3-((8S,9S,10R,13S,14S)-10,13-Dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine


  • Catalogue No.:PAI 01 040020

  • CAS :

    NA

  • Molecular Formula : C24H31N

  • Molecular Weight : 333.52

Drug Reference Standards & Impurity Synthesis in India
PAI 01 050010

((1aS,1bR,2S,7aS)-1-Bromo-1b,4-dimethoxy-5-methyl-3,6-dioxo-1a,1b,2,3,6,6b,7,7a-octahydro-1H-benzo[4,5]pentaleno[1,2-b]azirin-2-yl)methyl carbamate

((1aS,1bR,2S,7aS)-1-Bromo-1b,4-dimethoxy-5-methyl-3,6-dioxo-1a,1b,2,3,6,6b,7,7a-octahydro-1H-benzo[4,5]pentaleno[1,2-b]azirin-2-yl)methyl carbamate


  • Catalogue No.:PAI 01 050010

  • CAS :

    NA

  • Molecular Formula : C17H19BrN2O6

  • Molecular Weight : 427.25

Drug Reference Standards & Impurity Synthesis in India
PAI 01 040021

(10R,13S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

(10R,13S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol


  • Catalogue No.:PAI 01 040021

  • CAS :

    NA

  • Molecular Formula : C24H31NO

  • Molecular Weight : 349.52

Drug Reference Standards & Impurity Synthesis in India
PAI 01 040022

(10R,13S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl 4-methylbenzenesulfonate

(10R,13S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl 4-methylbenzenesulfonate


  • Catalogue No.:PAI 01 040022

  • CAS :

    NA

  • Molecular Formula : C31H37NO3S

  • Molecular Weight : 503.70

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261000

(3S,10R,13S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1Hcyclopenta[a]phenanthren-3-yl 2,2,2-trifluoroacetate;

(3S,10R,13S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1Hcyclopenta[a]phenanthren-3-yl 2,2,2-trifluoroacetate;


  • Catalogue No.:PA 28 0261000

  • CAS :

    1802323-89-2

  • Molecular Formula : C22H26F6O5S

  • Molecular Weight : 516.50

Drug Reference Standards & Impurity Synthesis in India
PA 01 04900

(3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate

(3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate


  • Catalogue No.:PA 01 04900

  • CAS :

    186826-68-6

  • Molecular Formula : C47H61NO4

  • Molecular Weight : 703.99

Drug Reference Standards & Impurity Synthesis in India
PA 01 04910

(3β)-16-[(3β)-3-Hydroxyandrosta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol

(3β)-16-[(3β)-3-Hydroxyandrosta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol


  • Catalogue No.:PA 01 04910

  • CAS :

    186826-70-0

  • Molecular Formula : C43H57NO2

  • Molecular Weight : 619.92

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261001

Abiraterone propionate

Abiraterone propionate


  • Catalogue No.:PA 28 0261001

  • CAS :

    1620323-43-4

  • Molecular Formula : C27H35NO2

  • Molecular Weight : 405.58

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261002

5,6-Dihydroabiraterone

5,6-Dihydroabiraterone


  • Catalogue No.:PA 28 0261002

  • CAS :

    219843-75-1

  • Molecular Formula : C24H33NO

  • Molecular Weight : 351.53

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261008

3,5-Cyclo-Abiraterone

3,5-Cyclo-Abiraterone


  • Catalogue No.:PA 28 0261008

  • CAS :

    NA

  • Molecular Formula : C24H31NO

  • Molecular Weight : 349.52

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261003

3-((3R,8R,9S,10R,13S,14S)-3-((3S,8R,9S,10R,13S,14S)-2,3,4,5,8,9,10,11,12,13,14,15-Dodecahydro-10,13-dimethyl-17-(pyridin-3-yl)-1H-cyclopenta[a]phenanthren-3-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-10,13-dimethyl-1H-cyclopenta[a]phenanthren-17-yl)pyridine

3-((3R,8R,9S,10R,13S,14S)-3-((3S,8R,9S,10R,13S,14S)-2,3,4,5,8,9,10,11,12,13,14,15-Dodecahydro-10,13-dimethyl-17-(pyridin-3-yl)-1H-cyclopenta[a]phenanthren-3-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-10,13-dimethyl-1H-cyclopenta[a]phenanthren-17-yl)pyridine


  • Catalogue No.:PA 28 0261003

  • CAS :

    NA

  • Molecular Formula : C48H60N2O

  • Molecular Weight : 681.02

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261004

17-(3-Pyridinyl)-androst-4-en-3-one

17-(3-Pyridinyl)-androst-4-en-3-one


  • Catalogue No.:PA 28 0261004

  • CAS :

    1382474-09-0

  • Molecular Formula : C24H31NO

  • Molecular Weight : 349.52

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261005

Abiraterone pregnenolone-16-ene acetate 21-triflate

Abiraterone pregnenolone-16-ene acetate 21-triflate


  • Catalogue No.:PA 28 0261005

  • CAS :

    2484719-08-4

  • Molecular Formula : C24H31F3O6S

  • Molecular Weight : 504.56

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261006

Abiraterone-5,6-epoxide

Abiraterone-5,6-epoxide


  • Catalogue No.:PA 28 0261006

  • CAS :

    NA

  • Molecular Formula : C24H31NO2

  • Molecular Weight : 365.52

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261007

3β-17-Imino-androst-5-en-3-ol dimer

3β-17-Imino-androst-5-en-3-ol dimer


  • Catalogue No.:PA 28 0261007

  • CAS :

    491873-45-1

  • Molecular Formula : C38H56N2O2

  • Molecular Weight : 572.88

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261009

N,N-Bis(trifluoromethyl)pyridin-2-amine

N,N-Bis(trifluoromethyl)pyridin-2-amine


  • Catalogue No.:PA 28 0261009

  • CAS :

    2517968-74-8

  • Molecular Formula : C7H4F6N2

  • Molecular Weight : 230.11

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261010

4-(((3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-4-oxobutanoic acid

4-(((3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-4-oxobutanoic acid


  • Catalogue No.:PA 28 0261010

  • CAS :

    1629778-77-3

  • Molecular Formula : C28H35NO4

  • Molecular Weight : 449.59

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261011

Abiraterone Acetate Di Acetoxy Dimer

Abiraterone Acetate Di Acetoxy Dimer


  • Catalogue No.:PA 28 0261011

  • CAS :

    1613026-24-6

  • Molecular Formula : C42H60N2O4

  • Molecular Weight : 656.95

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261012

(3S,8S,9S,10R,13S,14S,17S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

(3S,8S,9S,10R,13S,14S,17S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate


  • Catalogue No.:PA 28 0261012

  • CAS :

    98449-11-7

  • Molecular Formula : C26H35NO2

  • Molecular Weight : 393.57

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261013

(3S,8R,9S,10R,13S,14S)-17-Acetyl-10,13-dimethyl-7-oxo-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

(3S,8R,9S,10R,13S,14S)-17-Acetyl-10,13-dimethyl-7-oxo-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate


  • Catalogue No.:PA 28 0261013

  • CAS :

    19324-55-1

  • Molecular Formula : C23H30O4

  • Molecular Weight : 370.49

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261014

(3S,8R,9S,10R,13S,14S)-17-(1-(Hydroxyimino)ethyl)-10,13-dimethyl-7-oxo-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

(3S,8R,9S,10R,13S,14S)-17-(1-(Hydroxyimino)ethyl)-10,13-dimethyl-7-oxo-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate


  • Catalogue No.:PA 28 0261014

  • CAS :

    NA

  • Molecular Formula : C23H31NO4

  • Molecular Weight : 385.5

Drug Reference Standards & Impurity Synthesis in India
PAI 01 040023

(8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl trifluoromethanesulfonate

(8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl trifluoromethanesulfonate


  • Catalogue No.:PAI 01 040023

  • CAS :

    2697127-18-5

  • Molecular Formula : C25H28F3NO3S

  • Molecular Weight : 479.56

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261015

(2aS,4S,6aS,6bS,8aS,8bR,9aR,10aS,10bR)-6a,8a-Dimethyl-8b-(pyridin-3-yl)hexadecahydro-1H-naphtho[2',1':4,5]indeno[1,2-b]oxiren-4-yl Acetate

(2aS,4S,6aS,6bS,8aS,8bR,9aR,10aS,10bR)-6a,8a-Dimethyl-8b-(pyridin-3-yl)hexadecahydro-1H-naphtho[2',1':4,5]indeno[1,2-b]oxiren-4-yl Acetate


  • Catalogue No.:PA 28 0261015

  • CAS :

    219843-78-4

  • Molecular Formula : C26H35NO3

  • Molecular Weight : 409.57

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261016

5,16-Androstadien-3-ol

5,16-Androstadien-3-ol


  • Catalogue No.:PA 28 0261016

  • CAS :

    1224-94-8

  • Molecular Formula : C19H28O

  • Molecular Weight : 272.43

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261017

(3S,8R,9S,10S,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,8R,9S,10S,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol


  • Catalogue No.:PA 28 0261017

  • CAS :

    1382475-29-7

  • Molecular Formula : C24H33NO

  • Molecular Weight : 351.53

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261018

(3R,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl propionate

(3R,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl propionate


  • Catalogue No.:PA 28 0261018

  • CAS :

    NA

  • Molecular Formula : C27H35NO2

  • Molecular Weight : 405.58

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261019

2-(((3S,8S,9S,10R,14S)-10,17-Dimethyl-2,3,4,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)tetrahydro-2H-pyran

2-(((3S,8S,9S,10R,14S)-10,17-Dimethyl-2,3,4,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)tetrahydro-2H-pyran


  • Catalogue No.:PA 28 0261019

  • CAS :

    NA

  • Molecular Formula : C24H36O2

  • Molecular Weight : 356.55

Drug Reference Standards & Impurity Synthesis in India
PA 28 0261020

(3S,3'S,8R,8'R,9S,9'S,10R,10'R,13S,13'S,14S,14'S,17E,17'E)-17,17'-(Hydrazine-1,2-diylidene)bis(10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol)

(3S,3'S,8R,8'R,9S,9'S,10R,10'R,13S,13'S,14S,14'S,17E,17'E)-17,17'-(Hydrazine-1,2-diylidene)bis(10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol)


  • Catalogue No.:PA 28 0261020

  • CAS :

    1713262-50-0

  • Molecular Formula : C38H56N2O2

  • Molecular Weight : 572.88

pharmaffiliates